Skip navigation
  • Sciety Labs 🧪 (Experimental)
  • Search
Sciety application utilities

Infectious Diseases (except HIV/AIDS)

  • Subscribe to feed (RSS)

Showing page 388 of 716 pages of list content

  • Antibody Responses After a Single Dose of ChAdOx1 nCoV-19 Vaccine in Healthcare Workers Previously Infected with SARS-CoV-2

    This article's authors
    1. Sebastian Havervall
    2. Ulrika Marking
    3. Nina Greilert-Norin
    4. Henry Ng
    5. Ann-Christin Salomonsson
    6. Cecilia Hellström
    7. Elisa Pin
    8. Kim Blom
    9. Sara Mangsbo
    10. Mia Phillipson
    11. Jonas Klingström
    12. Mikael Ã…berg
    13. Sophia Hober
    14. Peter Nilsson
    15. Charlotte Thålin
    This article has 1 evaluations Latest evaluation on May 14, 2021 Published on May 11, 2021
  • Quantifying the potential dominance of immune-evading SARS-CoV-2 variants in the United States

    This article's authors
    1. Pratha Sah
    2. Thomas N. Vilches
    3. Affan Shoukat
    4. Meagan C. Fitzpatrick
    5. Abhishek Pandey
    6. Burton H. Singer
    7. Seyed M. Moghadas
    8. Alison P. Galvani
    This article has 1 evaluations Latest evaluation on May 14, 2021 Published on Aug 18, 2021
  • The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population: A survey of routine laboratory RT-PCR test results from the region of Münster, Germany

    This article's authors
    1. Andreas Stang
    2. Johannes Robers
    3. Birte Schonert
    4. Karl-Heinz Jöckel
    5. Angela Spelsberg
    6. Ulrich Keil
    7. Paul Cullen
    This article has 1 evaluations Latest evaluation on May 14, 2021 Published on May 19, 2021
  • Meta-analysis of rapid direct-to-PCR assays for the qualitative detection of SARS-CoV-2

    This article's authors
    1. T.A. Reginald
    2. S. Grippon
    3. M.J. Coldwell
    4. H. Chen
    5. L. Koh
    6. U. Jan
    7. A. Sanchez-Bretano
    8. D. Borley
    9. P. Oladimeji
    10. N. Moore
    11. S.P. Kidd
    12. J.E. Martin
    This article has 1 evaluations Latest evaluation on May 14, 2021 Published on Sep 16, 2021
  • Evolution of COVID-19 symptoms during the first 9 months after illness onset

    This article's authors
    1. Elke Wynberg
    2. Hugo van Willigen
    3. Maartje Dijkstra
    4. Anders Boyd
    5. Neeltje A. Kootstra
    6. Joost G. van den Aardweg
    7. Marit J. van Gils
    8. Amy Matser
    9. Marije R. de Wit
    10. Tjalling Leenstra
    11. Godelieve de Bree
    12. Menno D. de Jong
    13. Maria Prins
    14. the RECoVERED Study Group
    This article has 1 evaluations Latest evaluation on May 14, 2021 Published on May 11, 2021
  • Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes

    This article's authors
    1. Nguyen Lam Vuong
    2. Phung Khanh Lam
    3. Damien Keng Yen Ming
    4. Huynh Thi Le Duyen
    5. Nguyet Minh Nguyen
    6. Dong Thi Hoai Tam
    7. Duong Thi Hue Kien
    8. Nguyen Van Vinh Chau
    9. Ngoun Chanpheaktra
    10. Lucy Chai See Lum
    11. Ernesto Pleités
    12. Cameron P. Simmons
    13. Kerstin Rosenberger
    14. Thomas Jaenisch
    15. David Bell
    16. Nathalie Acestor
    17. Christine Halleux
    18. Piero L. Olliaro
    19. Bridget A. Wills
    20. Ronald B. Geskus
    21. Sophie Yacoub
    This article has 4 evaluations Latest evaluation on May 12, 2021 Published on Mar 15, 2021
  • LACK OF ASSOCIATION BETWEEN CONVALESCENT PLASMA ADMINISTRATION AND LENGTH OF HOSPITAL STAY: A HOSPITAL-DAY STRATIFIED MULTI-CENTER RETROSPECTIVE COHORT STUDY

    This article's authors
    1. Joy Alamgir
    2. M. Ruhul Abid
    3. Brian Garibaldi
    4. Naved Munir
    5. Soko Setoguchi
    6. Stephanie S. Hong
    7. Xinci Chen
    8. Paul T. Kocis
    9. Masanao Yajima
    10. G. Caleb Alexander
    11. Hemalkumar B. Mehta
    12. Vithal Madhira
    13. Rosa Ergas
    14. Thomas R. O’Brien
    15. Sam Bozzette
    This article has 1 evaluations Latest evaluation on May 11, 2021 Published on May 8, 2021
  • Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure

    This article's authors
    1. Mammen P. Mammen
    2. Pablo Tebas
    3. Joseph Agnes
    4. Mary Giffear
    5. Kimberly A. Kraynyak
    6. Elliott Blackwood
    7. Dinah Amante
    8. Emma L. Reuschel
    9. Mansi Purwar
    10. Aaron Christensen-Quick
    11. Nieman Liu
    12. Viviane M. Andrade
    13. Julie Carter
    14. Gabriella Garufi
    15. Malissa C. Diehl
    16. Albert Sylvester
    17. Matthew P. Morrow
    18. Patrick Pezzoli
    19. Abhijeet J. Kulkarni
    20. Faraz I. Zaidi
    21. Drew Frase
    22. Kevin Liaw
    23. Hedieh Badie
    24. Keiko O. Simon
    25. Trevor R.F. Smith
    26. Stephanie Ramos
    27. Robert Spitz
    28. Robert J. Juba
    29. Jessica Lee
    30. Michael Dallas
    31. Ami Shah Brown
    32. Jacqueline E. Shea
    33. J. Joseph Kim
    34. David B. Weiner
    35. Kate E. Broderick
    36. Jean D. Boyer
    37. Laurent M. Humeau
    This article has 1 evaluations Latest evaluation on May 11, 2021 Published on May 7, 2021
  • High Dose Convalescent Plasma in COVID-19: Results from the Randomized Trial CAPSID

    This article's authors
    1. Sixten Körper
    2. Manfred Weiss
    3. Daniel Zickler
    4. Thomas Wiesmann
    5. Kai Zacharowski
    6. Victor M.Corman
    7. Beate Grüner
    8. Lucas Ernst
    9. Peter Spieth
    10. Philipp M. Lepper
    11. Martin Bentz
    12. Sebastian Zinn
    13. Gregor Paul
    14. Johannes Kalbhenn
    15. Matthias Dollinger
    16. Peter Rosenberger
    17. Thomas Kirschning
    18. Thomas Thiele
    19. Thomas Appl
    20. Benjamin Mayer
    21. Michael Schmidt
    22. Christian Drosten
    23. Hinnerk Wulf
    24. Jan Matthias Kruse
    25. Bettina Jungwirth
    26. Erhard Seifried
    27. Hubert Schrezenmeier
    28. for the CAPSID Clinical Trial Group
    This article has 1 evaluations Latest evaluation on May 12, 2021 Published on May 10, 2021
  • Clinical evaluation of BD Veritorâ„¢ SARS-CoV-2 and Flu A+B Assay for point-of-care (POC) System

    This article's authors
    1. Katherine Christensen
    2. Huimiao Ren
    3. Shirley Chen
    4. Charles K. Cooper
    5. Stephen Young
    This article has 1 evaluations Latest evaluation on May 7, 2021 Published on May 4, 2021
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information